Immatics NV (IMTX)
6.39
-0.13
(-1.99%)
USD |
NASDAQ |
Nov 13, 16:00
6.39
0.00 (0.00%)
After-Hours: 19:59
Immatics Enterprise Value : 510.09M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 510.09M |
| November 11, 2026 | 535.98M |
| November 10, 2026 | 494.87M |
| November 09, 2026 | 496.39M |
| November 06, 2026 | 485.73M |
| November 05, 2026 | 458.32M |
| November 04, 2026 | 569.48M |
| November 03, 2026 | 594.60M |
| November 02, 2026 | 592.32M |
| October 30, 2026 | 613.63M |
| October 29, 2026 | 630.38M |
| October 28, 2026 | 636.47M |
| October 27, 2026 | 622.77M |
| October 26, 2026 | 606.02M |
| October 23, 2026 | 630.38M |
| October 22, 2026 | 665.41M |
| October 21, 2026 | 688.25M |
| October 20, 2026 | 660.84M |
| October 19, 2026 | 590.79M |
| October 16, 2026 | 542.07M |
| October 15, 2026 | 604.50M |
| October 14, 2026 | 583.18M |
| October 13, 2026 | 557.30M |
| October 12, 2026 | 615.16M |
| October 09, 2026 | 648.66M |
| Date | Value |
|---|---|
| October 08, 2026 | 639.52M |
| October 07, 2026 | 651.70M |
| October 06, 2026 | 659.31M |
| October 05, 2026 | 694.34M |
| October 02, 2026 | 673.02M |
| October 01, 2026 | 802.45M |
| September 30, 2026 | 854.22M |
| September 29, 2026 | 737.05M |
| September 28, 2026 | 728.85M |
| September 25, 2026 | 711.08M |
| September 24, 2026 | 705.61M |
| September 23, 2026 | 742.52M |
| September 22, 2026 | 779.42M |
| September 21, 2026 | 758.92M |
| September 18, 2026 | 745.25M |
| September 17, 2026 | 772.59M |
| September 16, 2026 | 747.98M |
| September 15, 2026 | 742.52M |
| September 14, 2026 | 745.25M |
| September 11, 2026 | 768.49M |
| September 10, 2026 | 763.02M |
| September 09, 2026 | 812.23M |
| September 08, 2026 | 857.34M |
| September 04, 2026 | 873.74M |
| September 03, 2026 | 860.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioNTech SE | 5.828B |
| MediGene AG | -- |
| InflaRx NV | 52.58M |
| Twist Bioscience Corp. | 7.085B |
| Prime Medicine, Inc. | 720.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -87.46M |
| Revenue (Quarterly) | 7.965M |
| Total Expenses (Quarterly) | 95.43M |
| EPS Diluted (Quarterly) | -0.6063 |
| Profit Margin (Quarterly) | -1.10K% |
| Earnings Yield | -30.83% |
| Normalized Earnings Yield | -30.53 |